[1] LOZANO R, NAGHAVI M, FOREMAN K, et al.Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010:a systematic analysis for the Global Burden of Disease Study 2010[J].Lancet, 2012, 380(9859):2095.
[2] 中华医学会心血管病学分会肺血管病学组, 中华心血管病杂志编委会.中国肺高血压诊断和治疗指南2018[J].中华心血管病杂志, 2018, 46(12):933.
[3] 王昌明, 王会娟.高迁移率族蛋白B1与慢性阻塞性肺疾病继发肺动脉高压的关系[J].中国老年学杂志, 2013, 33(20):5221.
[4] WANG F, NI SS, LIU H.Pollutional haze and COPD:etiology, epidemiology, pathogenesis, pathology, biological markers and therapy[J].J Thorac Dis, 2016, 8(1):E20.
[5] ANTUS B, KARDOS Z.Oxidative stress in COPD:molecular background and clinical monitoring[J].Curr Med Chem, 2015, 22(5):627.
[6] GUTTERIDGE JM, HALLIWELL B.Free radicals and antioxidants in the year 2000.A historical look to the future[J].Ann N Y Acad Sci, 2000, 899:136.
[7] SADOWSKA AM, VERBRAECKEN J, DARQUENNES K, et al.Role of N-acetylcysteine in the management of COPD[J].Int J Chron Obstruct Pulmon Dis, 2006, 1(4):425.
[8] MDNTES DE OCA M, PEREZ-PADILLA R.Global Initiative for Chronic Obstructive Lung Disease(GOLD)-2017:The alat perspective[J].Arch Bronconeumol, 2017, 53(3):87.
[9] 初巍巍, 霍阳, 王莉, 等.N-乙酰半胱氨酸对慢性阻塞性肺疾病急性加重期患者血清中氧化相关物质的影响[J].解放军医药杂志, 2014, 26(1):40.
[10] TOKGOZOGLU SL, CANER B, KABAKCI G, et al.Measurement of right ventricularejection fraction by contrast echocardiography[J].Int J Cardiol, 1997, 59(1):71.
[11] AOSHIBA K.Roles of apoptosis, cell senescence, and DNA damage in the pathogenetic mechanism of COPD[J].Nihon Rinsho, 2011, 69(10):1754.
[12] 刘凌云, 曾勉.氧化应激与慢性阻塞性肺疾病[J].国外医学呼吸系统分册, 2005, 25(10):733.
[13] 林洪, 刘晓妍, 王达安, 等.N-乙酰半胱氨酸对肺心病患者血浆血管性血友病因子、丙二醛含量和超氧化物岐化酶活性的影响[J].临床荟萃, 2008, 23(7):490.
[14] 彭文鸿, 邹霞英, 毛宝龄, 等.慢性阻塞性肺疾病和肺心病患者血液动力学与循环内皮细胞变化[J].中华结核和呼吸感染, 1998, 20(11):678.
[15] GAN WQ, MAN SF, SENTHIL SELVAN A, et al.Association between chronic obstructive pulmonary disease and systemic inflammation:a systematic review and a metaanalysis[J].Thorax, 2004, 59:574.
[16] 徐蓓峥, 罗勇, 施静, 等.慢性阻塞性肺疾病急性加重期患者血清PCT、CRP动态变化及回归分析[J].临床肺科杂志, 2016, 21(8):1368.
[17] SIN DD, MAN SF.Is systemic inflammation responsible for pulmonary hypertension in COPD[J].Chest, 2006, 130(2):310.
[18] KHAYYAT A, TOBWALA S, HART M, et al.N-acetylcysteine amide, a promising antidote for acetaminophen toxicity[J].Toxicol Lett, 2016, 241:133.
[19] 中国呼吸科专家组.祛痰抗氧化药治疗慢性阻塞性肺疾病中国专家共识[J].国际呼吸杂志, 2015, 35(8):1201.
[20] 韩冰, 孟晓, 卜培莉.N-乙酰半胱氨酸对野百合碱诱导大鼠肺动脉高压作用机制的基础研究[J].中国免疫学杂志, 2016, 32(3):345.
[21] VECCHIAL L, VAROTTO L, ZANOLLA L, et al.Right ventricular function predicts transplant free survival in idiopathic dilated cardiomyopathy[J].J Cardiovasc Med(Hagerstown), 2006, 7(9):706.
[22] LAROSE E, GANZ P, REYNOLDS HG, et al.Right ventricular dysfunction assessed by cardiovascular magnetic resonance imaging predicts poor prognosis late after myocardial infarction[J].J Am Coll Cardiol, 2007, 49(8):855.